ORIGINAL ARTICLE COPD Skeletal muscle adiposity associated physical activity exercise capacity fibre shift COPD Matthew Maddocks125 Dinesh Shrikrishna35 Simone Vitoriano12 Samantha A Natanek3 Rebecca J Tanner3 Nicholas Hart4 Paul R Kemp3 John Moxham12 Michael I Polkey3 Nicholas S Hopkinson3 Affiliations 1Dept Palliative Care Policy Rehabilitation Kings College London London UK 2Dept Asthma Allergy Lung Biology Kings College London London UK 3National Heart Lung Institute NIHR Respiratory Biomedical Research Unit Royal Brompton Harefield NHS Foundation Trust Imperial College London UK 4NIHR Comprehensive Biomedical Research Centre Guys St Thomas NHS Foundation Trust Kings College London London UK 5Both authors contributed equally Correspondence Nicholas S Hopkinson National Heart Lung Institute Royal Brompton Hospital Fulham Road London SW3 6NP UK Email nhopkinsonicacuk ABSTRACT Quadriceps muscle phenotype varies widely patients chronic obstructive pulmonary disease COPD determined muscle biopsy We hypothesised measures skeletal muscle adiposity provide noninvasive biomarkers muscle quality population In 101 patients 10 agematched healthy controls midthigh crosssectional area percentage intramuscular fat skeletal muscle attenuation calculated computed tomography images standard tissue attenuation ranges fat 190 30 HU skeletal muscle 29150 HU MeanSD percentage intramuscular fat higher patient group 6735 versus 4312 p5003 Both percentage intramuscular fat skeletal muscle attenuation associated physical activity level exercise capacity type I fibre proportion independent age midthigh crosssectional area quadriceps strength Combined transfer factor lung carbon monoxide variables identify 80 patients fibre type shift 65 specificity area curve 083 95 CI 072095 Skeletal muscle adiposity assessed computed tomography reflects multiple aspects COPD related muscle dysfunction help identify patients trials interventions targeted specific muscle phenotypes ERSpublications CTbased skeletal muscle adiposity markers reflect muscle quality COPD help identify patients fibre shift httpowlyxolWA This article supplementary material available erjersjournalscom Received Jan 08 2014 Accepted revision May 23 2014 First published online July 03 2014 Support statement M Maddocks National Institute Health Research NIHR PostDoctoral Research Fellow NS Hopkinson Higher Education Funding Council England HEFCE Clinical Senior Lecturer The study supported NIHR Respiratory Biomedical Research Unit Royal Brompton Harefield NHS Foundation Trust Imperial College London fund MI Polkeys salary The views expressed publication authors necessarily NHS NIHR Department Health Conflict None declared Copyright cid2ERS 2014 ERJ Open articles open access distributed terms Creative Commons Attribution NonCommercial Licence 40 1188 Eur Respir J 2014 44 11881198 DOI 1011830903193600066414 COPD M MADDOCKS ET AL Introduction Skeletal muscle dysfunction important complication chronic obstructive pulmonary disease COPD occurring mild advanced disease 1 2 It largely driven physical inactivity apparent muscles lower limb particular quadriceps 3 4 Quadriceps weakness associated reduced exercise performance 5 poor health status 6 increased healthcare utilisation 7 mortality independent airflow obstruction 8 Changes quadriceps include muscle atrophy loss strength endurance 9 10 shift aerobic phenotype reduced type I fibre proportions capillarity oxidative enzymes 11 12 The degree nature impairment varies widely patients currently predicted accurately muscle biopsy 13 The need biomarkers muscle phenotype recently highlighted underscored prospect new pharmacotherapies selectively target certain muscle characteristics 14 For example peroxisome proliferatoractivated receptord agonists 59 AMPactivated protein kinase activators change fuel preference skeletal muscle away glycolysis fat oxidation Computed tomography CT established method assess muscle mass quantity 15 Images analysed assess muscle quality level fatty infiltration muscle muscle adiposity Skeletal muscle adiposity increases age 16 independent mass associated muscle triglyceride content 17 oxidative capacity 18 insulin resistance 19 muscle strength power 20 21 immobility hip fracture 22 23 Little known muscle adiposity patients COPD given predicted CTbased measures valuable biomarkers muscle phenotype group In particular use help identify patients type I type II muscle fibre shift candidates trials targeted therapies In study hypothesised midthigh intramuscular fat muscle attenuation associated physical activity exercise capacity fibre shift Methods Study design subjects Data collated patients diagnosis COPD consistent Global Initiative Chronic Obstructive Lung Disease GOLD criteria 24 previously participated clinical studies Royal Brompton Kings College St Thomas Hospitals London UK Some phenotypic data patients previously reported 6 25 Exclusion criteria diagnoses heart renal liver failure systemic inflammatory metabolic neuromuscular disorders warfarin bleeding risk biopsy exacerbation preceding 4 weeks Healthy agematched controls history symptoms respiratory cardiovascular disease unresolved musculoskeletal injury recruited local advertisement All participants provided written informed consent studies approved Joint University College London Committees Ethics Human Research Committee Alpha Ethics Committee Royal Brompton Harefield NHS Foundation Trust Midthigh composition CT performed 64slice CT scanner SOMATOM Sensation 64 Siemens Erlangen Germany patient supine position A single section midthighs predefined level obtained following acquisition parameters 50 mAs 120 kVp The protocol modified deliver reduced radiation scan Images viewed analysed SliceOMatic software version 43 TomoVision Magog QC Canada Skeletal muscle intramuscular fat identified quantified use standard Hounsfield unit thresholds represent physical properties tissues expressed numerical form skeletal muscle 29150 HU intramuscular fat 190 30 HU 26 By specifying Hounsfield unit range software filters tissue type allows quantified turn Tissue perimeters altered manually necessary fig 1 Intramuscular fat normalised midthigh crosssectional area MTCSA expressed percentage Skeletal muscle attenuation measured mean radiation attenuation Hounsfield units reflects macroscopic fatty muscle infiltration A lower mean indicates attenuation greater fat infiltration These methods highly reliable reported intra inter class coefficients variation 02 48 27 28 Additional measurements Lung volumes transfer factor lung carbon monoxide TLCO fat mass fat free mass index FFMI daily step count physical activity level PAL quadriceps maximum voluntary contraction QMVC twitch tension vastus lateralis fibre type shift exercise capacity assessed incremental shuttle walk test ISWT 6min walking distance 6MWD healthrelated quality life assessed described previously 6 25 online supplementary material DOI 1011830903193600066414 1189 COPD M MADDOCKS ET AL FIGURE 1 Midthigh compositional analysis based single slice computed tomography image Tissues differentiated according standardised Hounsfield unit thresholds skeletal muscle red 29150 HU adipose tissue green 190 30 HU Statistical analysis Normally distributed continuous data presented meanSD Betweengroup comparisons performed unpaired ttest Chisquared tests oneway ANOVA appropriate Associations measures skeletal muscle adiposity variables analysed Pearsons correlation coefficients univariate multivariate linear regression models incorporating age MTCSA QMVC TLCO predicted independent variables For receiver operating characteristic ROC analysis percentage intramuscular fat skeletal muscle attenuation combination discriminate subjects according presence fibre shift Statistical analysis graphical presentations performed SPSS version 19 IBM Corp Armonk NY USA GraphPad Prism 5 GraphPad Software Inc San Diago CA USA respectively No attempt imputation missing data A pvalue 005 regarded statistically significant Results Subjects CT data available 111 subjects 101 COPD patients 10 healthy agematched controls table 1 Consistent diagnosis COPD patients impaired lung function reduced arterial blood oxygen tension compared controls There significant differences age body mass index FFMI arterial blood carbon dioxide tension patient healthy control groups patients significantly reduced quadriceps strength midthigh lean tissue crosssectional area table 1 Percentage intramuscular fat significantly elevated patients COPD compared healthy controls meanSD values 6633 4312 respectively p5003 In patient group 1190 DOI 1011830903193600066414 COPD M MADDOCKS ET AL TABLE 1 Subject characteristics Healthy COPD pvalue 10 46 68073 1669 758146 27237 22497 488121 16927 145 1015 259064 10613 372095 12119 69957 597132 10511 231055 10212 396 679152 8713 534047 1128102 8299 31592 7421 2218449 2121425 42340 11851 430123 48997 44385 3246 475101 57281 Subjects Malesfemales Age years Height cm Weight Body mass index kgm2 Fat mass Fatfree mass Fatfree mass index kgm2 Currentformerneversmoker Smoking packyears FEV1 L FEV1 predicted VC L VC predicted FEV1VC TLC L TLC predicted RV L RV predicted RVTLC TLCO L TLCO predicted PCO2 kPa PO2 kPa GOLD stage IIIIIIIV GOLD grade ABCD Exacerbations past year Medication n Longacting bagonist Inhaled corticosteroid Oral steroid 5 mgday1 Oxygen Nocturnal NIV SGRQ QMVC Quadriceps twitch force Body composition thighs MTCSA cm2 Lean tissue crosssectional area cm2 Lean tissue HU Intramuscular fat cm2 Intramuscular fat Fibre type I IIa IIx II Exercise capacity 6MWD m ISWT m Physical activity Wear time h day Wear time TEE kcal day Steps day PAL 101 6041 64876 1699 700151 24548 27060 47790 16824 25760 4924 108054 4120 300079 8919 358138 734174 12319 426149 18960 5612 349158 4219 520070 961153 4263140 941969 1 02 85 84 85 84 8 8 18 18 8 8 499190 26774 9731 1909476 1780444 41548 13074 664332 282125 570134 121131 679152 341141 250132 23605 98302 1976332 45013273 141017 020 021 042 025 009 015 071 085 001 001 001 001 001 001 001 002 001 001 001 001 001 001 055 001 001 005 004 004 002 063 064 003 001 001 002 001 001 Data presented n meanSD median interquartile range stated COPD chronic obstructive pulmonary disease FEV1 forced expiratory volume 1 s VC vital capacity TLC total lung capacity RV residual volume TLCO transfer factor lung carbon monoxide PCO2 carbon dioxide tension PO2 oxygen tension GOLD Global Initiative Chronic Obstructive Lung Disease NIV noninvasive ventilation SGRQ St Georges respiratory questionnaire QMVC quadriceps maximum voluntary contraction MTCSA midthigh crosssectional area 6MWD 6min walking distance ISWT incremental shuttle walk test TEE total energy expenditure PAL physical activity level COPD fibre type n548 ISWT n530 6MWD physical activity n569 DOI 1011830903193600066414 1191 COPD M MADDOCKS ET AL values stratified GOLD stage revealed fat infiltration tended greater advanced disease group differences significant GOLD IIIIIIIV 50055905 79076405 table 1 Skeletal muscle attenuation numerically significantly different patient control groups table 1 significantly reduced patients fat infiltration table 2 Reproducibility For measures based standard CT image mean differences researchers repeat assessments researcher 1 mean value assessments The lower 95 confidence intervals correlation coefficients assessments exceeded 099 interpreted excellent tables S1a S1b A subset 29 patients additional CT scan following 3 months participation placebo arm clinical trial Overall repeat assessments demonstrated good reproducibility lower 95 confidence intervals correlation coefficients exceeding 070 table S1c Skeletal muscle adiposity physical activity Percentage intramuscular fat negatively correlated step count r5 027 p5003 PAL r5 035 p50003 fig 2 PAL significantly reduced patients upper compared lower quartile measure p5004 table 2 In regression model percentage intramuscular fat significantly associated step count b coefficientSE 258121 p5004 PAL bSE 002001 p50007 independent age MTCSA QMVC TLCO pred Skeletal muscle attenuation positively correlated step count r5036 p50003 PAL r5035 p50004 fig 2 significantly associated variables independent age MTCSA QMVC TLCO pred step count bSE 206100 p5002 PAL bSE 013001 p50008 Skeletal muscle adiposity exercise capacity Percentage intramuscular fat negatively correlated ISWT r5 045 p0001 6MWD analysed r5 049 p50001 r5 042 p5002 control subjects fig 3 ISWT 6MWD significantly reduced patients upper quartile percentage intramuscular fat compared lower quartile table 2 Percentage intramuscular fat significantly associated ISWT bSE 16045 p0001 6MWD bSE 19562 p50004 independent age MTCSA QMVC TLCO pred Skeletal muscle attenuation positively correlated ISWT distance r5037 p50002 6MWD analysed r5057 p50001 r5060 p50001 control subjects fig 3 significantly associated exercise performance independent age MTCSA QMVC TLCO pred ISWT bSE 9838 p50001 6MWD bSE 12738 p50002 Skeletal muscle adiposity fibre shift Percentage intramuscular fat negatively correlated percentage type I fibres analysed r5 036 p50006 r5 027 p5005 control subjects fig S1 Percentage type I fibres significantly different patients upper lower quartile percentage intramuscular fat percentage type IIx fibres significantly greater patients fat infiltration 218184 versus 8487 p5004 Percentage intramuscular fat independently associated percentage type I fibres considered age MTCSA QMVC TLCO pred bSE 1306 p5004 In similar analysis skeletal muscle attenuation positively correlated percentage type I fibres r5030 p5002 fig S1b independently associated factors considered To determine measures skeletal muscle adiposity predict fibre shift ROC analysis performed fibre shift defined percentage type I fibres f27 dependent variable TLCO pred stronger predictor fibre shift percentage intramuscular fat skeletal muscle attenuation area curve AUC values 95 CI 0825 07090940 0648 074940802 respectively fig 4 Combining measures skeletal muscle adiposity TLCO pred AUC increased 0833 fig 4 The curve profile changed greater emphasis sensitivity specificity measures skeletal muscle adiposity TLCO pred identify 80 patients fibre shift 65 specificity fig 4 Skeletal muscle adiposity COPD characteristics Neither percentage intramuscular fat skeletal muscle attenuation significantly associated sex body mass index FFMI MTCSA QMVC The measures consistently related physical activity exercise capacity fibre shift measures skeletal muscle adiposity table S2 Percentage 1192 DOI 1011830903193600066414 COPD M MADDOCKS ET AL TABLE 2 Clinical characteristics chronic obstructive pulmonary disease patients stratified upper lower quartile percentage intramuscular fat Lower quartile Upper quartile pvalue Subjects Malesfemales Age years Height cm Weight Body mass index kgm2 Fat mass Fatfree mass Fatfree mass index kgm2 Smoking packyears FEV1 L FEV1 predicted VC L VC predicted FEV1VC TLC L TLC predicted RV L RV predicted RVTLC TLCO L TLCO predicted PCO2 kPa PO2 kPa GOLD stage IIIIIIIV GOLD grade ABCD Exacerbations past year Medication n Longacting bagonist Inhaled corticosteroid Oral steroid 5 mgday1 Oxygen Nocturnal NIV SGRQ QMVC Quadriceps twitch force Body composition thighs MTCSA cm2 Lean tissue crosssectional area cm2 Lean tissue HU Intramuscular fat cm2 Intramuscular fat Fibre type I IIa IIx II Exercise capacity 6MWD m ISWT m Physical activity Wear time h day Wear time TEE kcal day Steps day PAL 25 178 63473 1698 639152 22042 16164 477105 16726 4919 116062 4221 337084 9418 326134 79815 12914 454125 20158 5215 366172 4218 521043 1025138 17611 22318 1 02 21 84 21 84 3 12 4 16 0 0 472212 25482 10330 1909492 1850484 44947 5821 294080 293133 609163 8487 693141 404166 295138 23704 98716 1961412 46323407 144017 25 1510 66463 168287 759155 26752 26095 49880 17126 5729 098043 3715 283085 8517 352118 697173 11616 409117 17942 597 298149 3718 527092 911172 05137 10217 1 02 22 88 22 88 2 8 8 32 4 16 565135 26176 9027 1882504 1671450 37649 21171 1122220 218105 593116 210184 768114 18883 17288 23703 98811 1925296 30732167 133012 038 014 060 001 0001 0001 043 061 032 025 042 003 008 049 004 0005 021 014 008 018 035 076 002 019 027 045 046 020 050 016 003 009 076 021 085 019 0001 0001 0001 014 079 004 068 003 0003 087 081 076 011 004 Data presented n meanSD median interquartile range stated FEV1 forced expiratory volume 1 s VC vital capacity TLC total lung capacity RV residual volume TLCO transfer factor lung carbon monoxide PCO2 carbon dioxide tension PO2 oxygen tension GOLD Global Initiative Chronic Obstructive Lung Disease NIV noninvasive ventilation SGRQ St Georges respiratory questionnaire QMVC quadriceps maximum voluntary contraction MTCSA midthigh crosssectional area 6MWD 6min walking distance ISWT incremental shuttle walk test TEE total energy expenditure PAL physical activity level comparison limited n514 versus n511 fibre type n56 versus n55 6MWD n519 versus n518 ISWT physical activity measures intramuscular fat significantly associated characteristics assessed fat mass r5038 p0001 Skeletal muscle attenuation associated age r5 030 p50002 TLCO pred r5030 p50003 quadriceps twitch force r5037 p5001 MTCSA r5022 p5002 fat mass r5 019 p5004 DOI 1011830903193600066414 1193 COPD M MADDOCKS ET AL 15 000 b 15 000 t n u o c p e t s y l D c L A P 12 000 9000 6000 3000 0 0 20 18 16 14 12 10 r 027 p003 15 10 5 Intramuscular fat 20 r 035 p0003 t n u o c p e t s y l D d L A P 12 000 9000 6000 3000 0 20 20 18 16 14 12 10 0 15 10 5 Intramuscular fat 20 20 r036 p0003 30 40 Skeletal muscle attenuation HU 50 r035 p0004 30 40 Skeletal muscle attenuation HU 50 60 60 FIGURE 2 Relationship c midthigh percentage intramuscular fat b d skeletal muscle attenuation physical inactivity assessed b mean daily step count c d physical activity level PAL Discussion We investigated CTbased measures skeletal muscle adiposity patients COPD Patients significantly elevated percentage intramuscular fat compared agematched healthy controls Moderate significant associations percentage intramuscular fat skeletal muscle attenuation measures physical activity exercise capacity muscle fibre type independent age quadriceps strength MTCSA By combining measures skeletal muscle adiposity TLCO 80 subjects quadriceps fibre shift identified 65 specificity Significance findings Our findings extend knowledge extent nature quadriceps muscle dysfunction COPD Reductions muscle mass strength endurance known phenomena fibre shift loss oxidative capacity 8 9 13 Abnormally high levels lipids observed microscopically quadriceps patients COPD fascia 29 muscle fibres 30 31 Imagebased measures quadriceps muscle structure help identify patients specific muscle phenotypes Muscle biopsy data confirm COPD muscle abnormalities heterogeneous unrelated muscle strength average 50 unselected patients pathological fibre shift fibre atrophy 13 For emerging pharmacotherapies fibretype specific modes action affect transcriptional coactivator 32 stimulate fatty acid oxidation 33 practical biomarkers identify relevant populations study desirable Other biomarkers suggested purpose including 31Pmagnetic resonance spectroscopy MRS 34 plasma microRNA1 35 CT measures expensive undertake 31PMRS likely rapidly available stable biomarker based blood analysis Our findings support data suggesting emphysema evaluated TLCO airflow obstruction closely associated skeletal muscle abnormalities 36 strength 37 FEV1 differs review GOSKER et al 11 FEV1 strongly associated TLCO study level For study stratification CT advantage scored centrally patient operatordependent gas transfer measurement The accumulation fat skeletal muscle patients COPD reflect intermediate type I type II fibre shift insulin resistance Oxidative muscle fibres consume fats 38 results consistent observation transgenic animal models increased skeletal muscle oxidative fibre proportion reduced intramuscular triglyceride content compared wildtype 1194 DOI 1011830903193600066414 COPD M MADDOCKS ET AL r037 p0002 r 049 p00001 15 10 5 Intramuscular fat 20 b m e c n t s d T W S I 800 600 400 200 0 20 30 40 Skeletal muscle attenuation HU 50 d 800 r 045 p00001 r057 p0001 m D W M 6 600 400 200 0 20 15 10 5 Intramuscular fat 20 30 40 Skeletal muscle attenuation HU 50 60 60 m e c n t s d T W S I 800 600 400 200 0 0 c 800 m D W M 6 600 400 200 0 0 FIGURE 3 Relationship c midthigh percentage intramuscular fat b d skeletal muscle attenuation exercise capacity assessed b incremental shuttle walk test ISWT c d 6min walking distance 6MWD controls exposed highfat diet 39 In humans type I type II fibre shift associated insulin resistance obesity 40 41 intramuscular fat associated 42 exacerbate insulin resistance 43 Fat skeletal muscle reflect fat tissue body exceeding storage capacity subsequent release fatty acids circulation Thus intramuscular fat facilitate stratified medicine approach biomarker insulin resistance cardiovascular risk COPD generally The investigated measures fasting insulin levels example skeletal muscle adiposity euglycaemic insulin clamp studies 44 prospective observation cardiovascular events patients COPD levels intramuscular fat known Functional exercise performance associated percentage intramuscular fat skeletal muscle attenuation Given link physical inactivity muscle fibre shift probably reflects reduced quadriceps oxidative capacity endurance leading early fatigue This consolidates previous data 10 08 06 04 02 y t v t s n e S 00 00 02 intramuscular fat HU TLCO pred intramuscular fat HU TLCO pred Reference line 04 06 1Speciﬁcity AUC 95 CI 0648 04940802 0825 07090940 0833 07200947 08 10 FIGURE 4 Receiver operating characteristic curves transfer factor lung carbon monoxide TLCO predicted measures skeletal muscle adiposity areas curve AUC 95 CI Optimal sensitivityspecificity values dark solid line 889500 833667 778822 722911 DOI 1011830903193600066414 1195 COPD M MADDOCKS ET AL group demonstrated patients fibre shift poorer exercise performance independent differences MTCSA quadriceps strength 25 Relationship work Two small studies previously demonstrated greater levels intramuscular fat patients COPD compared healthy controls CT magnetic resonance imaging 45 46 Neither demonstrated association measures skeletal muscle adiposity functional performance SHEILDS et al 47 recently demonstrated increased intermuscular fat assessed magnetic resonance imaging quadriceps patients COPD compared healthy controls mean increase 32 As present study fat infiltration muscle crosssectional area associated increased anaerobic metabolism exercise reduced exercise performance 47 Bioenergetic changes observed biceps brachii despite patients having selected basis weakness quadriceps 47 Critique method Interobserver interoccasion agreement measures skeletal muscle adiposity based standard CT image excellent narrower limits agreement reported measurement rectus femoris crosssectional area ultrasound 48 Studies CT report coefficients variation 15 25 tissue crosssectional area 1 muscle attenuation 49 HU increase equivalent 1 increase lipid concentration assessed microscopically 17 Differences serial measurements 3 months patients stable COPD small comparable CTbased measures muscle adipose crosssectional area confirmed axial cadaver sections 50 51 The small measurement differences ascribed operator error particularly manual correction tissue margins required absence fully automated analysis procedure Error relating image acquisition minimal particularly comparison modalities rely surface landmarking example ultrasound Nonetheless marginally greater differences compared observers underscores need training standardisation observers longitudinal measurements insufficient Muscle biopsies obtained large subset subjects study Samples fibre typing measure inflammatory markers mediators fulfil aims primary studies Unfortunately tissue remained stain intermyocellular intramyocellular fat deposition served criterion measures validate CTbased measures surrogate markers muscle adiposity Direct measures intramyocellular fat myofilament density measures muscle phenotype capillarisation oxidative enzyme content glucose handling helpful examine population Future longitudinal work explore accumulation mechanisms intramuscular fat responsiveness change CTbased measurements ability help predict clinical outcome example treatment response risk admission cardiovascular events In older adults 12 weeks highintensity resistance training shown increase quadriceps hamstring muscle attenuation 54 55 respectively concurrent changes strength mass 52 Skeletal muscle attenuation predict communitybased falls hip fracture functional mobility independent strength 22 23 Conclusion In conclusion skeletal muscle adiposity assessed CT imaging reflects important aspects muscle dysfunction patients COPD help identify patients fibre shift Future work identify responsiveness intervention proven therapies example exercise training novel drugs specific muscle phenotypes expected respond differently Acknowledgements We thank patients kindly agreed participate studies members Lung Function Department Royal Brompton Hospital London UK testing study participants Seymour JM Spruit M Hopkinson NS et al The prevalence quadriceps weakness COPD relationship disease severity Eur Respir J 2010 36 8188 Kelly JL Elkin SL Fluxman J et al Breathlessness skeletal muscle weakness patients undergoing lung health screening primary care COPD 2013 10 4054 Watz H Waschki B Boehme C et al Extrapulmonary effects chronic obstructive pulmonary disease physical activity crosssectional study Am J Respir Crit Care Med 2008 177 743751 Man WD Soliman M Nikoletou D et al Nonvolitional assessment skeletal muscle strength patients chronic obstructive pulmonary disease Thorax 2003 58 665669 References 1 2 3 4 1196 DOI 1011830903193600066414 COPD M MADDOCKS ET AL 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Gosselink R Troosters T Decramer M Peripheral muscle weakness contributes exercise limitation COPD Am J Respir Crit Care Med 1996 153 976980 Shrikrishna D Patel M Tanner RJ et al Quadriceps wasting physical inactivity patients COPD Eur Respir J 2012 40 11151122 Decramer M Gosselink R Troosters T et al Muscle weakness related utilization health care resources COPD patients Eur Respir J 1997 10 417423 Swallow EB Reyes D Hopkinson NS et al Quadriceps strength predicts mortality patients moderate severe chronic obstructive pulmonary disease Thorax 2007 62 115120 Shrikrishna D Hopkinson NS Chronic obstructive pulmonary disease consequences lung Clin Med 2012 12 7174 Swallow EB Gosker HR Ward KA et al A novel technique nonvolitional assessment quadriceps muscle endurance humans J Appl Physiol 2007 103 739746 Gosker HR Zeegers MP Wouters EF et al Muscle fibre type shifting vastus lateralis patients COPD associated disease severity systematic review metaanalysis Thorax 2007 62 944949 van den Borst B Slot IG Hellwig VA et al Loss quadriceps muscle oxidative phenotype decreased endurance patients mildtomoderate COPD J Appl Physiol 2013 114 13191328 Natanek SA Gosker HR Slot IG et al Heterogeneity quadriceps muscle phenotype chronic obstructive pulmonary disease COPD implications stratified medicine Muscle Nerve 2013 48 488497 Steiner MC Roubenoff R TalSinger R et al Prospects development effective pharmacotherapy targeted skeletal muscles chronic obstructive pulmonary disease translational review Thorax 2012 67 11021109 Haggmark T Jansson E Svane B Crosssectional area thigh muscle man measured computed tomography Scand J Clin Lab Invest 1978 38 355360 Borkan GA Hults DE Gerzof SG et al Age changes body composition revealed computed tomography J Gerontol 1983 38 673677 Goodpaster BH Kelley DE Thaete FL et al Skeletal muscle attenuation determined computed tomography associated skeletal muscle lipid content J Appl Physiol 2000 89 104110 Simoneau JA Colberg SR Thaete FL et al Skeletal muscle glycolytic oxidative enzyme capacities determinants insulin sensitivity muscle composition obese women FASEB J 1995 9 273278 Goodpaster BH Thaete FL Simoneau JA et al Subcutaneous abdominal fat thigh muscle composition predict insulin sensitivity independently visceral fat Diabetes 1997 46 15791585 Goodpaster BH Carlson CL Visser M et al Attenuation skeletal muscle strength elderly Health ABC Study J Appl Physiol 2001 90 21572165 Visser M Kritchevsky SB Goodpaster BH et al Leg muscle mass composition relation lower extremity performance men women aged 70 79 health aging body composition study J Am Geriatr Soc 2002 50 897904 Visser M Goodpaster BH Kritchevsky SB et al Muscle mass muscle strength muscle fat infiltration predictors incident mobility limitations wellfunctioning older persons J Gerontol A Biol Sci Med Sci 2005 60 324333 Lang T Cauley JA Tylavsky F et al Computed tomographic measurements thigh muscle crosssectional area attenuation coefficient predict hip fracture health aging body composition study J Bone Miner Res 2010 25 513519 Vestbo J Hurd SS Agustı AG et al Global strategy diagnosis management prevention chronic obstructive pulmonary disease GOLD executive summary Am J Respir Crit Care Med 2013 187 347365 Natanek SA Gosker HR Slot IG et al Pathways associated reduced quadriceps oxidative fibres endurance COPD Eur Respir J 2013 41 12751283 31 30 28 27 29 26 Mourtzakis M Prado CM Lieffers JR et al A practical precise approach quantification body composition cancer patients computed tomography images acquired routine care Appl Physiol Nutr Metab 2008 33 9971006 Irving BA Weltman JY Brock DW et al NIH ImageJ SliceOMatic computed tomography imaging software quantify soft tissue Obesity 2007 15 370376 Strandberg S Wretling ML Wredmark T et al Reliability computed tomography measurements assessment thigh muscle crosssectional area attenuation BMC Med Imaging 2010 10 18 Pallas O Corominas J Gea J Degeneracio n mixoide en los mu sculos esqueleticos perifericos pacientes EPOC grave Parte la miopatıa periferica Is myxoid degeneration peripheral skeletal muscles patients severe COPD related peripheral myopathy Arch Bronconeumol 1999 35 143 Koechlin C Maltais F Saey D et al Hypoxaemia enhances peripheral muscle oxidative stress chronic obstructive pulmonary disease Thorax 2005 60 834841 Allaire J Maltais F LeBlanc P et al Lipofuscin accumulation vastus lateralis muscle patients chronic obstructive pulmonary disease Muscle Nerve 2002 25 383389 Remels AH Schrauwen P Broekhuizen R et al Peroxisome proliferatoractivated receptor expression reduced skeletal muscle COPD Eur Respir J 2007 30 245252 Narkar VA Downes M Yu RT et al AMPK PPARd agonists exercise mimetics Cell 2008 134 405415 Sala E Roca J Marrades RM et al Effects endurance training skeletal muscle bioenergetics chronic obstructive pulmonary disease Am J Respir Crit Care Med 1999 159 17261734 Lewis A RiddochContreras J Natanek SA et al Downregulation serum response factormiR1 axis quadriceps patients COPD Thorax 2012 67 2634 Rutten EP Grydeland TB Pillai SG et al Quantitative CT associations emphysema airway wall thickness body composition COPD Pulm Med 2011 2011 419328 Hopkinson NS Nickol AH Payne J et al Angiotensin converting enzyme genotype strength chronic obstructive pulmonary disease Am J Respir Crit Care Med 2004 170 395399 Blomstrand E Challiss RA Cooney GJ et al Maximal activities hexokinase 6phosphofructokinase oxoglutarate dehydrogenase carnitine palmitoyltransferase rat avian muscles Biosci Rep 1983 3 11491153 33 34 36 35 38 37 32 DOI 1011830903193600066414 1197 COPD M MADDOCKS ET AL 39 Wang YX Zhang CL Yu RT et al Regulation muscle fiber type running endurance PPARd PLoS Biol 40 41 42 43 44 45 2004 2 e294 Lillioja S Young AA Culter CL et al Skeletal muscle capillary density fiber type possible determinants vivo insulin resistance man J Clin Invest 1987 80 415424 Oberbach A Bossenz Y Lehmann S et al Altered fiber distribution fiberspecific glycolytic oxidative enzyme activity skeletal muscle patients type 2 diabetes Diabetes Care 2006 29 895900 Phillips DI Caddy S Ilic V et al Intramuscular triglyceride muscle insulin sensitivity evidence relationship nondiabetic subjects Metabolism 1996 45 947950 Hegarty BD Furler SM Ye J et al The role intramuscular lipid insulin resistance Acta Physiol Scand 2003 178 373383 van den Borst B Gosker HR Schols AM Central fat peripheral muscle partners crime chronic obstructive pulmonary disease Am J Respir Crit Care Med 2013 187 813 Roig M Eng JJ MacIntyre DL et al Deficits muscle strength mass quality mobility people chronic obstructive pulmonary disease J Cardiopulm Rehabil Prev 2011 31 120124 46 Mathur S MacIntyre DL Forster BB et al Preservation eccentric torque knee extensors flexors 47 48 patients COPD J Cardiopulm Rehabil Prev 2007 27 411416 Shields GS Coissi GS JimenezRoyo P et al Bioenergetic abnormailites intermuscular fat chronic obstructive pulmonary disease COPDassociated quadricpes weakness Muscle Nerve 2014 In press DOI 101002 mus24289 Seymour JM Ward K Sidhu PS et al Ultrasound measurement rectus femoris crosssectional area relationship quadriceps strength COPD Thorax 2009 64 418423 49 MacDonald AJ Greig CA Baracos V The advantages limitations crosssectional body composition analysis 50 Curr Opin Support Palliat Care 2011 5 342349 Hudash G Albright JP McAuley E et al Crosssectional assessment Med Sci Sports Exerc 1985 17 417421 thigh components computerized tomographic 51 Mitsiopoulos N Baumgartner R Heymsfield S et al Cadaver validation skeletal muscle measurement 52 magnetic resonance imaging computerized tomography J Appl Physiol 1998 85 115122 Taaffe DR Henwood TR Nalls MA et al Alterations muscle attenuation following detraining retraining resistancetrained older adults Gerontology 2009 55 217223 1198 DOI 1011830903193600066414